The CCDC170 gene helps cells keep part of their inner framework organized, which supports normal cell shape, movement, and growth. If the CCDC170 gene does not work as expected, cells may handle these jobs less smoothly, and some variants in or near this gene are linked to a higher chance of certain breast cancers. In medicine, this gene is watched most closely because changes involving CCDC170 can influence how some hormone sensitive breast cancers develop. The CCDC170 gene is not widely known outside medical settings, so it has had little direct public attention.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, which are the parts of cells that do the work. Other genes mainly help direct when certain processes happen, where they occur, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
CCDC170Gene function
What if the gene works
The CCDC170 gene helps cells organize their inner scaffolding and maintain shape. Its protein also supports normal traffic inside cells.
Risk
What if the gene does not work
Variants in the CCDC170 gene can range from milder to more severe and may weaken how cells organize microtubules, the internal fibers that help maintain shape and transport materials. This can disturb Golgi positioning and cell movement.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the CCDC170 gene does not currently change standard treatment or drug choices in any guideline-based way. In research, CCDC170 changes, especially ESR1–CCDC170 fusions in some breast cancers, are being studied as markers of hormone therapy resistance and as possible treatment targets.
Gene function
What if the gene works
Inside your cells, the CCDC170 gene helps organize parts of the inner cell scaffold. Its protein is linked to the Golgi apparatus, the cell’s packaging center, and to microtubules, tiny tracks that help hold shape and move cargo. Understanding how the CCDC170 gene works helps explain how cells keep their internal layout orderly.
The CCDC170 gene helps organize microtubules, the tiny support tracks that give cells shape and direction. This supports a steady internal layout so cell parts stay in the right place.
Its protein is linked to the Golgi apparatus, the cell’s packaging center for sorting and sending proteins. By helping arrange this area, it supports smooth movement of materials inside the cell.
What is a variant?
Small differences in the DNA sequence within a gene are called genetic variants. They are common and help explain normal variation among people, such as differences in appearance, metabolism, or the body’s response to environmental influences. Many variants do not cause any noticeable effects and are simply part of natural genetic variation. At times, though, a variant can more strongly change how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CCDC170 gene can change the protein’s shape or length, making it less stable or less able to interact with partner proteins. Research on how CCDC170 gene variants affect protein function suggests a spectrum, with milder variants causing small changes and more disruptive variants reducing protein production or creating a shortened protein. These effects are described mainly at the molecular and cellular level rather than as one inherited disease pattern.
How variants are linked to conditions
CCDC170 does not yet have a broadly confirmed link to a specific inherited health condition, though research on CCDC170 variants and disease risk is still evolving. Information about how CCDC170 variants are linked to conditions may change as larger studies clarify which findings are truly meaningful. If you carry a reported change in the CCDC170 gene, your result is best interpreted with your doctor or genetic counselor in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of being human and are found throughout the general population. Most do not have a direct impact on health and instead represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible connection rather than a firm diagnosis, especially when more than one gene and environmental factors play a role. In some instances, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to CCDC170 itself. For many living with a CCDC170 change, overall risk is more strongly shaped by the bigger picture, including family history, other genes, and non-genetic factors such as age and hormone exposure.
Inheritance of CCDC170 variants
There is not yet a broadly confirmed Mendelian inheritance pattern for CCDC170-related health conditions, so the way CCDC170 variants are inherited is not defined in the same clear way as for classic single-gene conditions. Current evidence mainly links some changes near or involving the CCDC170 gene to altered risk rather than a predictable inherited syndrome. The CCDC170 gene is located on chromosome 6, which is an autosome, so you inherit one copy from each parent. In that general sense, CCDC170 variants can be passed from either mother or father to sons or daughters.
What does my CCDC170 result mean for my family?
There is not yet a broadly confirmed family inheritance pattern tied to a specific health condition for CCDC170. If you have a CCDC170 result and want to understand what it could mean for relatives, a doctor or genetic counselor can help put that result in the right family context.
Genetic information
Genetic testing
How you find out about variants
Variants in the CCDC170 gene are found with DNA testing, usually from a blood or saliva sample. A lab reads the gene as part of a multigene panel or broader sequencing test and compares your result with reference DNA to look for changes. CCDC170 genetic testing can show whether a known variant is present, though results need clinical interpretation.
When should I consider getting a genetic test?
There is not yet a broadly established reason to order genetic testing specifically for the CCDC170 gene on its own. Decisions about testing are usually based on your personal and family history, especially of breast cancer, and are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals varies based on the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when viewed together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug faster or slower than expected, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, do little for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences affect how people respond to medicines. It focuses on links between genes and drugs to help explain why the same treatment can work differently in different people. For many medicines, genes can influence how strongly a drug works or how the body handles it. This understanding can support treatment choices that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the CCDC170 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting medication response, so questions about medicines, side effects, or treatment changes are best discussed with your doctor. CCDC170 has been studied in some breast cancers, especially when it is fused with ESR1, to see whether it may affect response to hormone-based treatment, but this is still a research area.